News and Events
All Articles
Could GLP-1s Cause Pharmacy Plan Bottom Lines to Balloon In 2025?
Balancing Cost and Care: Covering GLP-1s for Weight Management
4 Key Barriers Holding Biosimilars Back (and how to remove them)
Unlocking Pharmacy Value for Private Equity Firms
RxBenefits, Inc. Appoints Robert Gamble Chief Executive Officer
How To Break Through the Barriers Facing Biosimilars
The Cost Conundrum of GLP-1s and Their Impact on Pharmacy Spend
Pharmacy Times Part 2: What Went Wrong – How Formularies, Contracts, and Rebates Created a Headwind for Biosimilars
Chief Pharmacy Officer, Mark Campbell Featured in Pharmacy Times
Get Our Newsletter
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
